VAERS Explorer
Back to explore

Report #2854171

Received Aug 14, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
VA
Recovered
Unknown
Vaccinated
May 23, 2025
Onset
May 23, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.UNKY017516—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No additional AE; HCP reporting that a patient received a dose of improperly stored PROQUAD. Reference TE case #02843001. HCP reported that she did not know the date the excursion occurred, but knows the PROQUAD was administered following the excursion. HCP reported; Information has been received from Business Partner on 22-Jul-2025. This spontaneous report was received from a Other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 23-May-2025, the patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y017516, expiration date: 19-Apr-2026) (0.5mL), for an unknown indication. On 23-May-2025, the patient started therapy with sterile diluent (MERCK STERILE DILUENT), (indication, expiration date, and lot # were not reported). The vaccine underwent temperature excursion in 52.2 degree Fahrenheit (Improper storage of product in use). No additional adverse event was reported.

Other medications

sterile diluent